FibroScan
FibroScan is a medical procedure with 58 clinical trials. Currently 15 active trials ongoing. Historical success rate of 89.5%.
Success Metrics
Based on 17 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
85.0%
17 of 20 finished
15.0%
3 ended early
15
trials recruiting
58
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
EUS-Guided ATI and SWE in Individuals With Normal FibroScan
Evaluation of Fibroscan® Performance in Diagnosing Acute Heart Failure in Patients Presenting to the Emergency Department
Fibroscan® Medical Device, Assessment for Non Invasive Diagnosis of Liver Steatosis
Association Between Overt and Sub-clinical Primary Hypothyroidism and Metabolic Dysfunction-Associated Steatoic Liver Disease in Non-Diabetic Patients
Liver Biomarkers in Anorexia Nervosa
Clinical Trials (58)
EUS-Guided ATI and SWE in Individuals With Normal FibroScan
Evaluation of Fibroscan® Performance in Diagnosing Acute Heart Failure in Patients Presenting to the Emergency Department
Fibroscan® Medical Device, Assessment for Non Invasive Diagnosis of Liver Steatosis
Association Between Overt and Sub-clinical Primary Hypothyroidism and Metabolic Dysfunction-Associated Steatoic Liver Disease in Non-Diabetic Patients
Liver Biomarkers in Anorexia Nervosa
FibroScan-Reproducibility and Repeatability Study
Milk Thistle Clinical Trial in Pediatric NAFLD
Prevalence of NAFLD in T2DM Patients
Fibroscan Study in HCC
Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)
Effect of Parenteral Support on FibroScan in Short Bowel Syndrome
Endoscopic Ultrasound Shear Wave Elastography Study
PolyCystic Ovary Syndrome as Suggested Risk Group for Non-Alcoholic Fatty Liver Disease
Fatty Liver and Pancreatic Steatosis
Prevalence of NAFLD in T1DM Patients
Application of Comprehensive Non-invasive Assessment To Phenotype Tricuspid Regurgitation
Fibroscan Evaluating Immunotherapy Response in Hepatocellular Carcinoma
AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
Assessment of the Prevalence of Steatotic Liver Disease Associated With Metabolic Dysfunction in Patients With Heterozygous Familial Hypercholesterolemia
Thyroid Dysfunction and Its Association With Metabolic Dysfunction-Associated Fatty Liver Disease
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 58